Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Dizziness	O
and	O
low	O
heart	O
rate	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
an	O
___	O
with	O
atrial	O
fibrillation,	O
HTN,	O
HL,	O
COPD	O
on	O
home	O
O2,	O
AS	O
___	O
bioprosthetic	O
AVR,	O
MR	O
___	O
attempted	O
mitraclip	O
with	O
residual	O
3+	O
MR	O
who	O
presents	O
with	O
LH	O
and	O
found	O
to	O
again	O
be	O
bradycardic	O
to	O
the	O
40-50s.	O
She	O
was	O
on	O
Toprol	O
75mg	O
daily.	O
Her	O
Cr	O
was	O
found	O
to	O
be	O
elevated	O
at	O
the	O
outside	O
hospital	O
to	O
1.9.	O
Her	O
baseline	O
Cr	O
is	O
1.4.	O
Past	O
Medical	O
History:	O
-Dyslipidemia	O
-Hypertension	O
-Atrial	O
fibrillation-undergone	O
multiple	O
cardioversions	O
and	O
has	O
failed	O
antiarrythmic	O
therapy.	O
Remains	O
in	O
AF	O
-Aortic	O
stenosis,	O
___	O
Bioprosthetic	O
AVR	O
___	O
-Partial	O
flail	O
anterior	O
mitral	O
valve	O
leaflet	O
with	O
mod	O
to	O
severe	O
MR	O
-___	O
with	O
LVEF	O
ranging	O
40%	O
to	O
55%	O
more	O
recently	O
-Paroxysmal	O
SVT	O
-Non-obstructive	O
coronary	O
artery	O
disease	O
-Asthma	O
-COPD	O
-Significant	O
Nosebleed	O
___	O
___	O
nasal	O
tamponade	O
-Perforated	O
ear	O
drum	O
-GERD	O
-Depression	O
-Hypothyroidism	O
Social	O
History:	O
___	O
Family	O
History:	O
There	O
is	O
a	O
family	O
history	O
of	O
hypertension,	O
heart	O
disease,	O
and	O
strokes.	O
Her	O
mother	O
died	O
of	O
natural	O
causes.	O
Her	O
father	O
died	O
at	O
___	O
of	O
a	O
heart	O
attack.	O
Physical	O
Exam:	O
ADMISSION	O
PE:	O
T	O
afebrile,	O
BP	O
140/70,	O
P	O
40-50s,	O
R	O
18,	O
100%	O
on	O
2L	O
NC	O
Dry	O
weight:	O
123	O
pounds	O
Gen:	O
NAD	O
Neuro:	O
Grossly	O
intact	O
Neck/JVD:	O
JVP	O
elevated	O
at	O
10cm	O
H20	O
but	O
with	O
prominent	O
V-wave	O
CV:	O
Irregularly	O
irregular,	O
bradycardic,	O
___	O
systolic	O
murmur	O
at	O
___	O
and	O
also	O
at	O
apex	O
Chest:	O
Faint	O
crackles	O
at	O
bases	O
bilaterally;	O
no	O
wheezing	O
ABD:	O
soft,	O
NT,	O
ND,	O
NABS	O
Extr:	O
WWP,	O
no	O
edema	O
Access	O
sites:	O
PIV	O
Tele:	O
Afib	O
with	O
bradycardia	O
ECG:	O
Atrial	O
fibrillation	O
with	O
rate	O
of	O
44	O
DISCHARGE	O
PE:	O
VS:	O
98.2	O
157/76	O
67	O
20	O
94%	O
2L	O
Tele:	O
AF	O
brief	O
rates	O
to	O
130's	O
with	O
activity,	O
60-70's	O
at	O
baseline.	O
No	O
pauses	O
or	O
blocks	O
Gen:	O
___	O
yr	O
old	O
in	O
NAD,	O
anxious	O
to	O
go	O
home	O
Neck/JVD:	O
JVP	O
elevated	O
at	O
10cm	O
H20	O
but	O
with	O
prominent	O
V-wave	O
CV:	O
Irregularly	O
irregular,	O
bradycardic,	O
___	O
systolic	O
murmur	O
at	O
LLSB	O
and	O
also	O
at	O
apex	O
Chest:	O
Faint	O
crackles	O
at	O
bases	O
bilaterally;	O
no	O
wheezing	O
ABD:	O
soft,	O
non-tender,	O
BS	O
+	O
Extr:	O
Radial	O
and	O
pedal	O
pulses	O
palpable.	O
No	O
edema.	O
Extremities	O
are	O
warm	O
and	O
well	O
perfused	O
Neuro:	O
Alert	O
and	O
oriented	B-Delirium
x	O
2.	O
No	O
focal	O
deficits	O
or	O
asymmetries	O
noted	O
Pertinent	O
Results:	O
___	O
09:15PM	O
GLUCOSE-192*	O
UREA	O
N-47*	O
CREAT-1.6*	O
SODIUM-137	O
POTASSIUM-4.8	O
CHLORIDE-95*	O
TOTAL	O
CO2-30	O
ANION	O
GAP-17	O
___	O
06:25AM	O
BLOOD	O
WBC-7.3	O
RBC-3.71*	O
Hgb-10.5*	O
Hct-34.3	O
MCV-93	O
MCH-28.3	O
MCHC-30.6*	O
RDW-20.4*	O
RDWSD-68.5*	O
Plt	O
___	O
___	O
05:50AM	O
BLOOD	O
UreaN-36*	O
Creat-1.2*	O
Na-140	O
K-4.4	O
Cl-97	O
HCO3-40*	O
AnGap-7*	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
yr	O
ol	O
woman	O
with	O
extensive	O
medical	O
history	O
including	O
AF,	O
CHF,	O
COPD	O
and	O
HTN	O
with	O
prior	O
admits	O
for	O
bradycardia	O
in	O
the	O
___.	O
She	O
was	O
previously	O
evaluated	O
by	O
___	O
___	O
during	O
CHF/PNA	O
admit)	O
who	O
noted	O
the	O
patient	O
may	O
require	O
a	O
pacemaker	O
in	O
the	O
future	O
d/t	O
conduction	O
disease/bradycardia.	O
She	O
is	O
___	O
Mitraclip	O
last	O
summer	O
with	O
suboptimal	O
result,	O
still	O
has	O
3+	O
MR	O
along	O
with	O
3+	O
TR.	O
She	O
presented	O
to	O
___	O
with	O
worsening	O
dizziness	O
and	O
was	O
found	O
to	O
be	O
bradycardic	O
in	O
the	O
___	O
(mostly	O
low	O
___.	O
Also	O
noted	O
to	O
have	O
___	O
on	O
CKD	O
with	O
creat	O
to	O
1.9	O
(baseline	O
1.4).	O
She	O
was	O
transferred	O
to	O
___	O
for	O
evaluation	O
by	O
EP	O
for	O
possible	O
pacemaker	O
placement.	O
She	O
was	O
monitored	O
on	O
telemetry	O
and	O
her	O
Metoprolol	O
was	O
held.	O
She	O
had	O
no	O
HB	O
or	O
pauses,	O
and	O
remained	O
in	O
AF,	O
irreg,	O
irreg.	O
Her	O
HR	O
increased	O
at	O
times	O
to	O
130's	O
with	O
activity,	O
so	O
her	O
Metoprolol	O
was	O
re-started	O
at	O
25	O
mg	O
daily.	O
Her	O
Torsemide	O
and	O
Losartan	O
were	O
held	O
until	O
her	O
creatinine	O
returned	O
to	O
her	O
baseline.	O
She	O
remained	O
on	O
her	O
Coumadin,	O
and	O
her	O
INR	O
at	O
DC	O
was	O
2.4.	O
She	O
was	O
discharged	O
in	O
stable	O
condition	O
with	O
follow	O
up	O
on	O
___	O
with	O
her	O
PCP	O
for	O
INR/chem	O
7	O
and	O
follow	O
up	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Ipratropium-Albuterol	O
Inhalation	O
Spray	O
1	O
INH	O
IH	O
Q6H:PRN	O
SOB	O
2.	O
Fluticasone-Salmeterol	O
Diskus	O
(500/50)	O
1	O
INH	O
IH	O
BID	O
3.	O
Cetirizine	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Warfarin	O
5	O
mg	O
PO	O
DAILY16	O
5.	O
Donepezil	O
10	O
mg	O
PO	O
QHS	O
6.	O
Fluticasone	O
Propionate	O
NASAL	O
1	O
SPRY	O
NU	O
DAILY	O
7.	O
Levothyroxine	O
Sodium	O
75	O
mcg	O
PO	O
DAILY	O
8.	O
Magnesium	O
Oxide	O
400	O
mg	O
PO	O
DAILY	O
9.	O
Metoprolol	O
Succinate	O
XL	O
75	O
mg	O
PO	O
DAILY	O
10.	O
Potassium	O
Chloride	O
20	O
mEq	O
PO	O
DAILY	O
11.	O
Pravastatin	O
80	O
mg	O
PO	O
QPM	O
12.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
13.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
14.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
15.	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Cetirizine	O
10	O
mg	O
PO	O
DAILY	O
2.	O
Donepezil	O
10	O
mg	O
PO	O
QHS	O
3.	O
Fluticasone-Salmeterol	O
Diskus	O
(500/50)	O
1	O
INH	O
IH	O
BID	O
4.	O
Levothyroxine	O
Sodium	O
75	O
mcg	O
PO	O
DAILY	O
5.	O
Magnesium	O
Oxide	O
400	O
mg	O
PO	O
DAILY	O
6.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
7.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
8.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
9.	O
Pravastatin	O
80	O
mg	O
PO	O
QPM	O
10.	O
Warfarin	O
2.5	O
mg	O
PO	O
DAILY16	O
11.	O
Fluticasone	O
Propionate	O
NASAL	O
1	O
SPRY	O
NU	O
DAILY	O
12.	O
Ipratropium-Albuterol	O
Inhalation	O
Spray	O
1	O
INH	O
IH	O
Q6H:PRN	O
SOB	O
13.	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
DAILY	O
14.	O
Potassium	O
Chloride	O
20	O
mEq	O
PO	O
DAILY	O
Hold	O
for	O
K	O
>	O
15.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	B-Has_carers
With	B-Has_carers
Service	B-Has_carers
Facility:	O
___	O
___	O
Diagnosis:	O
Bradycardia	O
Chronic	O
diastolic	O
heart	O
failure	O
AF	O
on	O
Coumadin	O
COPD	O
___	O
on	O
CKD	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	O
requires	O
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
VS:	O
98.2	O
157/76	O
67	O
20	O
94%	O
2L	O
Tele:	O
AF	O
brief	O
rates	O
to	O
130's	O
with	O
activity,	O
60-70's	O
at	O
baseline.	O
No	O
pauses	O
or	O
blocks	O
Gen:	O
___	O
yr	O
old	O
in	O
NAD,	O
anxious	O
to	O
go	O
home	O
Neck/JVD:	O
JVP	O
elevated	O
at	O
10cm	O
H20	O
but	O
with	O
prominent	O
V-wave	O
CV:	O
Irregularly	O
irregular,	O
bradycardic,	O
___	O
systolic	O
murmur	O
at	O
LLSB	O
and	O
also	O
at	O
apex	O
Chest:	O
Faint	O
crackles	O
at	O
bases	O
bilaterally;	O
no	O
wheezing	O
ABD:	O
soft,	O
non-tender,	O
BS	O
+	O
Extr:	O
Radial	O
and	O
pedal	O
pulses	O
palpable.	O
No	O
edema.	O
Extremities	O
are	O
warm	O
and	O
well	O
perfused	O
Neuro:	O
Alert	O
and	O
oriented	B-Delirium
x	O
2.	O
No	O
focal	O
deficits	O
or	O
asymmetries	O
noted	O
Ms.	O
___	O
is	O
an	O
___	O
with	O
atrial	O
fibrillation,	O
HTN,	O
HL,	O
COPD	O
on	O
home	O
O2,	O
AS	O
___	O
bioprosthetic	O
AVR,	O
MR	O
___	O
attempted	O
mitraclip	O
with	O
residual	O
3+	O
MR	O
who	O
presents	O
with	O
LH	O
and	O
found	O
to	O
again	O
be	O
bradycardic	O
to	O
the	O
40-50s.	O
She	O
was	O
on	O
Toprol	O
75mg	O
daily.	O
Her	O
Cr	O
was	O
found	O
to	O
be	O
elevated	O
at	O
the	O
outside	O
hospital	O
to	O
1.9.	O
Her	O
baseline	O
Cr	O
is	O
1.4.	O
She	O
was	O
determined	O
not	O
to	O
need	O
a	O
pacemaker	O
at	O
this	O
time,	O
and	O
her	O
renal	O
function	O
has	O
returned	O
to	O
baseline	O
#.	O
Bradycardia	O
-resume	O
Metoprolol	O
at	O
lower	O
dose	O
of	O
25	O
mg	O
daily	O
#.	O
___	O
on	O
CKD	O
stage	O
III:	O
Baseline	O
creat	O
1.4.	O
Creat	O
1.2	O
today	O
-resume	O
home	O
Losartan	O
and	O
Torsemide	O
-Chem	O
7	O
on	O
___	O
#.	O
Chronic	O
diastolic	O
heart	O
failure:	O
stable	O
-resume	O
Torsemide	O
-daily	O
wts,	O
I+O,	O
low	O
salt	O
diet	O
#.	O
AF	O
on	O
Coumadin,	O
INR	O
2.9	O
today	O
-Resume	O
home	O
dose	O
of	O
2.5	O
mg	O
daily	O
-INR	O
check	O
on	O
___	O
-	O
Per	O
pt's	O
daughter,	O
the	O
pt	O
has	O
gotten	O
severe	O
nose	O
bleeds	O
when	O
the	O
INR	O
>	O
2.5.	O
Also-	O
her	O
Coumadin	O
dose	O
was	O
recently	O
increased	O
for	O
a	O
low	O
INR	O
in	O
the	O
setting	O
of	O
several	O
days	O
of	O
missed	O
Coumadin	O
doses	O
#.	O
Hypertension:	O
SBP	O
160's-170's	O
-	O
Resume	O
Losaratin	O
and	O
Torsemide	O
Discharge	O
Instructions:	O
You	O
were	O
transferred	O
from	O
___	O
to	O
___	O
to	O
evaluate	O
your	O
slow	O
heart	O
rate	O
and	O
worsening	O
kidney	O
function.	O
Your	O
heart	O
rhythm	O
and	O
kidney	O
function	O
were	O
closely	O
monitored,	O
and	O
it	O
was	O
determined	O
that	O
you	O
do	O
not	O
need	O
to	O
have	O
a	O
pacemaker	O
placed	O
at	O
this	O
time.	O
Your	O
Metoprolol	O
dose	O
was	O
decreased	O
to	O
25	O
mg	O
daily.	O
Initially,	O
your	O
Losartan	O
and	O
Torsemide	O
were	O
held	O
until	O
your	O
kidney	O
function	O
improved.	O
Please	O
resume	O
these	O
medications	O
upon	O
discharge	O
and	O
have	O
your	O
kidney	O
function	O
checked	O
on	O
___.	O
Your	O
INR	O
was	O
3.4,	O
so	O
your	O
Coumadin	O
was	O
held	O
for	O
one	O
night.	O
Your	O
INR	O
upon	O
discharge	O
is	O
2.9	O
Please	O
follow	O
up	O
to	O
have	O
your	O
INR	O
checked	O
on	O
___.	O
Weigh	O
yourself	O
every	O
morning,	O
and	O
call	O
your	O
MD	O
if	O
your	O
weight	O
increases	O
by	O
___	O
lbs	O
over	O
several	O
days.	O
Followup	O
Instructions:	O
___	O

